Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-26

Clinical Trial Update: Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel [EARLY_Phase 1]

View source ↗

Summary

A clinical trial comparing glycolic acid-salicylic acid peel versus glycolic acid peel for melasma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycolic Acid-Salicylic Acid Peel (glycolic acid-salicylic acid peel)
  • Glycolic acid peel (glycolic acid peel)

Snippet

Sponsor: Boston Medical Center | Conditions: Melasma | EARLY_Phase 1 | Status: WITHDRAWN